{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T03:47:01Z","timestamp":1770522421386,"version":"3.49.0"},"reference-count":53,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2010,4,16]],"date-time":"2010-04-16T00:00:00Z","timestamp":1271376000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[2010,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic>Objectives:<\/jats:italic>Tyrosine kinase inhibitors (TKIs) target various pathways associated with proliferation of aberrant clones in malignant diseases. Despite good response and acceptable tolerability, little is known concerning long\u2010term toxicity. Furthermore, the influence of these inhibitors on disease\u2010unrelated cells is not investigated yet.<jats:italic>Methods:<\/jats:italic>Centrosome aberrations are hallmarks of various cancers. We sought to evaluate the effect of TKIs on centrosomes of disease\u2010unrelated cells. We examined cells of the oral mucosa (OM) and fibroblasts of patients with chronic myeloid leukemia (CML) treated with dasatinib and bosutinib. Results were compared with data from patients with CML treated with imatinib or nilotinib and with data from patients suffering from renal and hepatocellular carcinomas (RCC\/HCC) treated with sorafenib or sunitinib. Cells of healthy donors served as controls.<jats:italic>Results:<\/jats:italic>OM cells (<jats:italic>n<\/jats:italic>\u2003=\u200312) and fibroblasts (<jats:italic>n<\/jats:italic>\u2003=\u20037) of patients with CML treated with dasatinib and OM cells of three patients with CML treated with bosutinib showed centrosomal alterations (mean, 14%) compared with 16 (10\u2003OM and 6 fibroblasts) controls (mean, 3%). OM cells of five patients with CML and one patient with systemic mastocytosis treated with imatinib or nilotinib and of eight patients with RCC or HCC treated with sorafenib or sunitinib showed centrosome defects in a mean of 15%.<jats:italic>Conclusions:<\/jats:italic>Our data have shown that TKI treatment of tumor patients may influence centrosomes in disease\u2010unrelated cells or tissues. This may be important with regard to various observed side effects.<\/jats:p>","DOI":"10.1111\/j.1600-0609.2010.01459.x","type":"journal-article","created":{"date-parts":[[2010,4,16]],"date-time":"2010-04-16T15:52:32Z","timestamp":1271433152000},"page":"139-148","source":"Crossref","is-referenced-by-count":12,"title":["Detection of centrosome aberrations in disease\u2010unrelated cells from patients with tumor treated with tyrosine kinase inhibitors"],"prefix":"10.1111","volume":"85","author":[{"given":"Michelle","family":"Giehl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armin","family":"Leitner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Haferlach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Duesberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolf\u2010Karsten","family":"Hofmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Hofheinz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Seifarth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Hochhaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Fabarius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,7,14]]},"reference":[{"key":"e_1_2_7_2_2","first-page":"1398","article-title":"Centrosome abnormalities and chromosome instability occur together in pre\u2010invasive carcinomas","volume":"63","author":"Pihan GA","year":"2003","journal-title":"Cancer Res"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403779"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2147"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-08-3097"},{"key":"e_1_2_7_6_2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0022-3565(24)38879-2","article-title":"Abl protein\u2010tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c\u2010kit and platelet\u2010derived growth factor receptors","volume":"295","author":"Buchdunger E","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.8.2440"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20922"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055104"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-04-083196"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.21.8230"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.4896"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1099480"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.84"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.156"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-1731"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0409770102"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-09-047266"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.01111"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.4920"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-2484"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-09-0075"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605366"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1586\/era.09.96"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/CAD.0b013e32833123d4"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200969020-00006"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.2174\/138920009788897975"},{"key":"e_1_2_7_28_2","first-page":"215","article-title":"Severe toxicity of skin rash, fever and diarrhea associated with imatinib: case report and review of skin toxicities associated with tyrosine kinase inhibitors","volume":"2","author":"Huang X","year":"2009","journal-title":"Drug Des Devel Ther"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1186\/1756-8722-2-46"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-09-180604"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1159\/000258880"},{"key":"e_1_2_7_32_2","first-page":"1","article-title":"Cardiotoxicity induced by tyrosine kinase inhibitors","volume":"4","author":"Orphanos GS","year":"2009","journal-title":"Acta Oncol"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403399"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.11064"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-04-017400"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403861"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06678.x"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.12793"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404834"},{"key":"e_1_2_7_40_2","volume-title":"An International System for Human Cytogenetic Nomenclature","author":"ISCN","year":"2005"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1038\/21704"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1038\/387520a0"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1206998"},{"key":"e_1_2_7_44_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1208438"},{"key":"e_1_2_7_45_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.emboj.7600393"},{"key":"e_1_2_7_46_2","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-07-0052"},{"key":"e_1_2_7_47_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.24.15.6788-6798.2004"},{"key":"e_1_2_7_48_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-0757"},{"key":"e_1_2_7_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1357-2725(99)00076-X"},{"key":"e_1_2_7_50_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510300140"},{"key":"e_1_2_7_51_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2003.12129.x"},{"key":"e_1_2_7_52_2","doi-asserted-by":"publisher","DOI":"10.1593\/neo.09408"},{"key":"e_1_2_7_53_2","first-page":"476","article-title":"Regulation of c\u2010Raf\u20101: therapeutic implications","volume":"1","author":"Beeram M","year":"2003","journal-title":"Clin Adv Hematol Oncol"},{"key":"e_1_2_7_54_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1075762"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.2010.01459.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.2010.01459.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T01:28:48Z","timestamp":1740014928000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.2010.01459.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,14]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["10.1111\/j.1600-0609.2010.01459.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.2010.01459.x","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,14]]}}}